Close

AcelRx Pharma (ACRX) to Present Statistically Significant ARX-04 Phase 3 Data in Abdominoplasty Patients

September 22, 2016 4:05 PM EDT Send to a Friend
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) announced that Dr. Shankar Lakshman, a board-certified plastic surgeon and AcelRx clinical investigator, will present ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login